Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer.
Wang H, Zhang S, Pan Q, Guo J, Li N, Chen L, Xu J, Zhou J, Gu Y, Wang X, Zhang G, Lian Y, Zhang W, Lin N, Jin Z, Zang Y, Lan W, Cheng X, Tan M, Chen FX, Jiang J, Liu Q, Zheng M, Qin J.
Wang H, et al. Among authors: xu j.
Nat Cancer. 2025 Apr;6(4):629-646. doi: 10.1038/s43018-025-00928-z. Epub 2025 Mar 18.
Nat Cancer. 2025.
PMID: 40102673